<
https://theconversation.com/were-on-track-to-eliminate-hepatitis-c-but-stigma-remains-and-reinfection-is-a-risk-216439>
"Hepatitis C is a preventable but potentially life-threatening blood-borne
virus. It primarily affects the liver and, if untreated, can lead to cirrhosis
(scar damage) and cancer.
When direct-acting antivirals for hepatitis C arrived in 2016, they were
described as a game changer. They cured chronic hepatitis C in more than 95% of
cases. So Australia adopted the World Health Organization’s target to eliminate
hepatitis C by 2030.
More than a billion dollars has been invested in adding direct-acting
antivirals to the Pharmaceutical Benefits Scheme, making treatment accessible
to anyone covered by Medicare. By the end of 2022, about 60% of people living
with hepatitis C had been treated.
That’s a remarkable public health achievement. Life-changing for many and for
some, literally life-saving. But what is life like for this growing group of
people after they’ve been cured? And where are we still lagging in our efforts
to combat hepatitis C?"
Cheers,
*** Xanni ***
--
mailto:xanni@xanadu.net Andrew Pam
http://xanadu.com.au/ Chief Scientist, Xanadu
https://glasswings.com.au/ Partner, Glass Wings
https://sericyb.com.au/ Manager, Serious Cybernetics
